Nivolumab vs Tacrolimus
Nivolumab vs Tacrolimus: Overview
This comparison examines the pharmacological differences between Nivolumab and Tacrolimus.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Tacrolimus: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Tacrolimus β 12 hours.
Chemical Properties
Molecular Formula: Tacrolimus β C44H69NO12.
Molecular Weight: Tacrolimus β 804.0180 g/mol.
Type: Nivolumab β Antibody; Tacrolimus β Small molecule.